Literature DB >> 29111266

Hepatoprotective and inhibiting HBV effects of polysaccharides from roots of Sophora flavescens.

Hua Yang1, Zhenhua Zhou2, Lifang He3, Hao Ma4, Wensheng Qu5, Jiye Yin6, Mengfan Jia7, Xiunan Zhao8, Junjie Shan8, Yueqiu Gao9.   

Abstract

Roots of Sophora flavescens is an important herbal medicine for treatment of HBV and hepatic carcinoma in China. Alkaloids in the root were well known for exhibiting good hepato-protective and anti-HBV effects. However, polysaccharides as main components in the root remained unknown. In the studies, we investigated the chemical features and hepatoprotective effects of Sophora flavescens polysaccharides (SFP-100 and its active fractions) with ConA-induced hepatitis mice, human liver LO2 cells and HepG2.2.15 cells. The results showed that SFP-100 was composed of arabinose, glucose, galactose and galacturonic acid, SFP-100-A mainly contained glucose. SFP-100-B and SFP-100-C were acidic polysaccharides. SFP-100 significantly decreased hepatocytes apoptosis, inhibited the infiltration of neutrophils and macrophages into liver, and improved the production of IFN-γ and IL-6 of splenocytes in ConA-induced hepatitis mice. SFP-100 and its two sugar fractions increased LO2 cell proliferation and reduced cell apoptosis induced by ConA. SFP-100, SFP-100-A and SFP-100-C remarkedly inhibited the secretion of HBsAg and HBeAg by HepG2.2.15 cells.These results suggested Sophora flavescens polysaccharides exerts significant hepatoprotective and anti-HBV roles, and further is used for treatment of immune-mediated liver disease in the future.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  ConA-induced liver injury; HBV; Polysaccharides; Sophora flavescens

Mesh:

Substances:

Year:  2017        PMID: 29111266     DOI: 10.1016/j.ijbiomac.2017.10.171

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  7 in total

1.  Effect of Hepatocyte Targeting Nanopreparation Syringopicroside on Duck Hepatitis B Virus and Evaluation of Its Safety.

Authors:  X W Zhang; M C Li; J J Dou
Journal:  Bull Exp Biol Med       Date:  2022-03-30       Impact factor: 0.804

2.  A Polysaccharide From Eupolyphaga sinensis Walker With Anti-HBV Activities In Vitro and In Vivo.

Authors:  Xue Zhang; Huiling Su; Haifei Yu; Jialu Ding; Wanyu Deng; Bo Qin; Changlin Zhou; Jie Dou; Min Guo
Journal:  Front Pharmacol       Date:  2022-03-03       Impact factor: 5.810

3.  The Effects of Qinghao-Kushen and Its Active Compounds on the Biological Characteristics of Liver Cancer Cells.

Authors:  Jingmin Ji; Zhiqin Zhang; Qing Peng; Liyuan Hao; Yinglin Guo; Yu Xue; Yiwei Liu; Caige Li; Xinli Shi
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-10       Impact factor: 2.650

4.  Yield, Nutritional Content, and Antioxidant Activity of Pleurotus ostreatus on Corncobs Supplemented with Herb Residues.

Authors:  Zhiqiang Jin; Yunling Li; Jiahong Ren; Nan Qin
Journal:  Mycobiology       Date:  2018-03-29       Impact factor: 1.858

5.  Efficiency of Sophora flavescens-Fructus Ligustri Lucidi Drug Pairs in the Treatment of Liver Fibrosis Based on the Response Surface Method.

Authors:  Shuhan Chu; Hongxu Zhang; Lixin Ding
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-01       Impact factor: 2.629

Review 6.  Wound Healing and the Use of Medicinal Plants.

Authors:  Aleksandra Shedoeva; David Leavesley; Zee Upton; Chen Fan
Journal:  Evid Based Complement Alternat Med       Date:  2019-09-22       Impact factor: 2.629

7.  Anti-HBV Activities of Polysaccharides from Thais clavigera (Küster) by In Vitro and In Vivo Study.

Authors:  Fei Tang; Guanghua Huang; Liping Lin; Hong Yin; Lili Shao; Ruian Xu; Xiuling Cui
Journal:  Mar Drugs       Date:  2021-03-30       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.